Senzime AB is one of 59 FDA 510(k) medical device manufacturers from Sweden in the dataset, ranked by real submission volume.
Senzime AB - FDA 510(k) Cleared Devices
Recent clearances: TetraGraph Neuromuscular Transmission Monitor (SEN 2015)Accessories:TetraSens (SEN 2012)TetraSens Pediatric (SEN 2013)TetraSensitive (SEN 2016)TetraHub (SEN 2017), Tetragraph Neuromuscular Transmission Monitor, Tetragraph Neuromuscular Transmission Monitor
3
Total
3
Cleared
0
Denied
Senzime AB has 3 FDA 510(k) cleared medical devices. Based in Uppsala, SE.
Latest FDA clearance: May 2026. Active since 2019. Primary specialty: Anesthesiology.
Browse the FDA 510(k) cleared devices submitted by Senzime AB Filter by specialty or product code using the sidebar.
Regulatory submissions have been managed by Obleix Consulting, LLC, Obelix Consulting and Obelix Consulting, LLC.
FDA 510(k) Regulatory Record - Senzime AB
3 devices